EUVIMEDEUVIMED entdecken
Open Access

Local and Sustained Baricitinib Delivery to the Skin through Injectable Hydrogels Containing Reversible Thioimidate Adducts

Leo L Wang iD, Spencer Tuohy, Karen L Xu, Arben Nace, Ruifeng Yang, Ying Zheng, Jason A Burdick, George Cotsarelis iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Leo L Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 1053 Biomedical Research Building, 421 Curie Blvd, Philadelphia, …. Hauptthemen laut MEDLINE: Hydrogels, Purines, Sulfonamides, Pyrazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Science Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Janus kinase (JAK) inhibitors are approved for many dermatologic disorders, but their use is limited by systemic toxicities including serious cardiovascular events and malignancy. To overcome these limitations, injectable hydrogels are engineered for the local and sustained delivery of baricitinib, a representative JAK inhibitor. Hydrogels are formed via disulfide crosslinking of thiolated hyaluronic acid macromers. Dynamic thioimidate bonds are introduced between the thiolated hyaluronic acid and nitrile‐containing baricitinib for drug tethering, which is confirmed with 1 H and 13 C nuclear magnetic resonance (NMR). Release of baricitinib is tunable over six weeks in vitro and active in inhibiting JAK signaling in a cell line containing a luciferase reporter reflecting interferon signaling. For in vivo activity, baricitinib hydrogels or controls are injected intradermally into an imiquimod‐induced mouse model of psoriasis. Imiquimod increases epidermal thickness in mice, which is unaffected when treated with baricitinib or hydrogel alone. Treatment with baricitinib hydrogels suppresses the increased epidermal thickness in mice treated with imiquimod, suggesting that the sustained and local release of baricitinib is important for a therapeutic outcome. This study is the first to utilize a thioimidate chemistry to deliver JAK inhibitors to the skin through injectable hydrogels, which has translational potential for treating inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsPurinesSulfonamidesPyrazolesAzetidinesSkinAnimalsMiceHumansPsoriasisImiquimodJanus Kinase InhibitorsFemale

Stichwörter der Autor:innen

JAK‐STATdermatologyhydrogelpsoriasisthioimidate

Substanzen

HydrogelsPurinesbaricitinibSulfonamidesPyrazolesAzetidinesImiquimodJanus Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 1053 Biomedical Research Building, 421 Curie Blvd, Philadelphia, PA, 19104, USA.
  • Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, 220 South 33rd Street, 107 Towne Building, Philadelphia, PA, 19104-6391, USA.
  • BioFrontiers Institute and Department of Chemical and Biological Engineering, College of Engineering and Applied Science, University of Colorado Boulder, 1111 Engineering Dr, Boulder, CO, 80309, USA.

ORCID-Profile: Leo L Wang, George Cotsarelis

Förderung

  • NIAMS NIH HHS
  • National Science Foundation
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Wang, L. L., Tuohy, S., Xu, K. L., Nace, A., Yang, R., Zheng, Y., Burdick, J. A., & Cotsarelis, G. (2024). Local and Sustained Baricitinib Delivery to the Skin through Injectable Hydrogels Containing Reversible Thioimidate Adducts. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303256

Vancouver

Wang LL, Tuohy S, Xu KL, Nace A, Yang R, Zheng Y, et al. Local and Sustained Baricitinib Delivery to the Skin through Injectable Hydrogels Containing Reversible Thioimidate Adducts. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303256

BibTeX
@article{Wang2024,
  author = {Wang, Leo L and Tuohy, Spencer and Xu, Karen L and Nace, Arben and Yang, Ruifeng and Zheng, Ying and Burdick, Jason A and Cotsarelis, George},
  title = {Local and Sustained Baricitinib Delivery to the Skin through Injectable Hydrogels Containing Reversible Thioimidate Adducts},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303256}
}
Kostenlos starten →